A randomised, phase II study of nintedanib or sunitinib in previously untreated patients with advanced renal cell cancer: 3-year results - Concepedia

Concepedia

Publication | Open Access

A randomised, phase II study of nintedanib or sunitinib in previously untreated patients with advanced renal cell cancer: 3-year results

DOI Full Paper Access

36

Citations

26

References

2015

Year

Tim Eisen, A-B. Loembé, Yaroslav Shparyk, Nicholas MacLeod, Robert J. Jones, Graham Temple, H Dressler, Igor Bondarenko

British Journal of Cancer

Abstract

In patients with advanced RCC, nintedanib has promising efficacy and similar tolerability to sunitinib, and a manageable safety profile with fewer TKI-associated AEs.

References

	Year	Citations

Page 1